Contattaci
Circa la società
Theolytics is a pre-clinical stage biotechnology company developing next-generation oncolytic viral therapies. The company was formed in 2017 to drive the development of a pipeline of novel clinical trial candidates, and is led by a team that combines over 40 years of experience in oncolytic virus development. The company uses an adenovirus platform to develop targeted, self-amplifying therapeutic agents, and aims to deliver innovative cancer care to millions of people in need worldwide.
GB
Sconosciuto
Azienda non verificata
Trasparenza aziendale
- Informazioni sull'azienda non verificate
- Chiedi ai loro clienti per le recensioni
- Non ha risposto alle recensioni negative